Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HA 155 (Autotaxin Inhibitor IV) is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 10,500 | |||
2 mg | 在庫あり | ¥ 14,500 | |||
5 mg | 在庫あり | ¥ 30,500 | |||
10 mg | 在庫あり | ¥ 54,500 | |||
25 mg | 在庫あり | ¥ 114,500 | |||
50 mg | 在庫あり | ¥ 159,000 | |||
100 mg | 在庫あり | ¥ 200,500 |
説明 | HA 155 (Autotaxin Inhibitor IV) is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine. |
ターゲット&IC50 | ATX:5.7 nM |
別名 | Autotaxin Inhibitor IV |
分子量 | 463.29 |
分子式 | C24H19BFNO5S |
CAS No. | 1229652-22-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Slightly soluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HA 155 1229652-22-5 Metabolism PDE inhibit Inhibitor HA-155 Phosphodiesterase (PDE) (E/Z)-HA155 Pain Cancer Autotaxin Inhibitor IV Inflammation Angiogenesis Fibrotic diseases HA155 Autotaxin inhibitor